Hearing device maker Cochlear has posted a rise in underlying full-year earnings and is looking for a stronger 2022/23 after the launch of its new sound processor.
Revenue grew 10 per cent to $1.6 billion in constant currency terms in the 12 months to June 30, as COVID-19 restrictions eased and hospitals resumed elective surgeries.
